WallStSmart

The Ensign Group Inc (ENSG)vsTenet Healthcare Corporation (THC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tenet Healthcare Corporation generates 315% more annual revenue ($21.86B vs $5.27B). THC leads profitability with a 7.8% profit margin vs 6.9%. ENSG appears more attractively valued with a PEG of 1.63. THC earns a higher WallStSmart Score of 72/100 (B).

ENSG

Buy

60

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 4.7Quality: 6.3
Piotroski: 6/9Altman Z: 2.34

THC

Strong Buy

72

out of 100

Grade: B

Growth: 6.7Profit: 7.5Value: 7.3Quality: 6.3
Piotroski: 6/9Altman Z: 1.69
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ENSGFair Value (-4.1%)

Margin of Safety

-4.1%

Fair Value

$203.60

Current Price

$182.03

$21.57 premium

UndervaluedFair: $203.60Overvalued
THCUndervalued (+78.9%)

Margin of Safety

+78.9%

Fair Value

$1070.59

Current Price

$186.91

$883.68 discount

UndervaluedFair: $1070.59Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ENSG2 strengths · Avg: 8.0/10
Revenue GrowthGrowth
18.4%8/10

18.4% revenue growth

EPS GrowthGrowth
21.9%8/10

Earnings expanding 21.9% YoY

THC5 strengths · Avg: 9.2/10
P/E RatioValuation
9.5x10/10

Attractively priced relative to earnings

Return on EquityProfitability
30.3%10/10

Every $100 of equity generates 30 in profit

EPS GrowthGrowth
87.6%10/10

Earnings expanding 87.6% YoY

Operating MarginProfitability
23.1%8/10

Strong operational efficiency at 23.1%

Free Cash FlowQuality
$1.46B8/10

Generating 1.5B in free cash flow

Areas to Watch

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.634/10

Expensive relative to growth rate

P/E RatioValuation
30.0x4/10

Moderate valuation

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

THC3 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.694/10

Distress zone — elevated risk

Profit MarginProfitability
7.8%3/10

7.8% margin — thin

PEG RatioValuation
4.312/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth, EPS Growth. Revenue growth of 18.4% demonstrates continued momentum.

Bull Case : THC

The strongest argument for THC centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 11.7% demonstrates continued momentum.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Bear Case : THC

The primary concerns for THC are Altman Z-Score, Profit Margin, PEG Ratio.

Key Dynamics to Monitor

ENSG profiles as a growth stock while THC is a value play — different risk/reward profiles.

THC carries more volatility with a beta of 1.50 — expect wider price swings.

ENSG is growing revenue faster at 18.4% — sustainability is the question.

THC generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

THC scores higher overall (72/100 vs 60/100) and 11.7% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Tenet Healthcare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?